Legemiddelindustrien

English

The Association of the Pharmaceutical Industry in Norway - LMI
Norwegian and foreign pharmaceutical companies selling medicinal products in Norway have their own trade organisation, Legemiddelindustriforeningen (LMI) – The Association of the Pharmaceutical Industry in Norway. LMI is working opposite the authorities, with the image and reputation of the industry, providing services towards the member companies, as well as making case assessments and supplying statistical reports. The association organises courses and training activities, e.g. conducting training courses for medical sales representatives and clinical trial monitors. LMI actively participates in international industry associations for manufacturers of pharmaceutical products.

• 

  Facts and figures 2012 Short version

  13.04.2012 / Medicines and the health service 2012.

• Business development in Norway

  16.01.2012 / LMI policy document.

• Medical progress for a better health

  05.11.2010 /

• EFPIA Code of Practice on relationships between the Pharmaceutical Industry and Patient Organisations

  13.07.2011 / Initially approved in 2007. Amended by decision of the General Assembly in June 2011.

• Rules for Marketing of Medicinal Products

  14.04.2011 / The most recent amendments from the General Meeting of the Association on 14. march 2011.

• Innovation and Collaboration: Preparing for and Responding to Global Pandemic Threats

  31.08.2009 / The research-Based Pharmaceutical Industry’s Role.

• Recommended guidelines between Patient Organisations and the Pharmaceutical Industry

  05.06.2008 / Implemented as of 1. June 2008.

• Norway uses an alternative to drug reference pricing

  21.05.2008 / Article in Scrip.

• Value of Vaccines: Two Centuries of Unparalleled Medical Progress

  21.05.2008 / A publication from IFPMA.

• Rules governing drug information

  14.05.2008 / Updated version of LMI`s Code of Practice.

• Les flere saker